| Followers | 19 |
| Posts | 6565 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Friday, May 19, 2023 3:51:19 AM
WISE WQLF SAID; KLASSNO LOGO. Black C on top of a White V. Have Mercy Have Partnerships Have Faith WISE WQLF
https://www.linkedin.com/company/cv-sciences
Status: Suspension check completed. Application remains suspended.
Status Date: Mar. 17, 2023
Refusals and requirement maintained and continued. The following refusals and requirement are maintained and continued:
Section 2(d) Refusal – Likelihood of Confusion
Sections 1 & 45 Refusal – FDCA Refusal – Class 005
Identification of Goods Requirement
https://tsdr.uspto.gov/#caseNumber=88694732&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
https://www.linkedin.com/company/cv-sciences
Status: Suspension check completed. Application remains suspended.
Status Date: Mar. 17, 2023
Refusals and requirement maintained and continued. The following refusals and requirement are maintained and continued:
Section 2(d) Refusal – Likelihood of Confusion
Sections 1 & 45 Refusal – FDCA Refusal – Class 005
Identification of Goods Requirement
https://tsdr.uspto.gov/#caseNumber=88694732&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
